Zuellig Pharma Opens Clinical Trial Support Center in South Korea
The establishment of this innovation center in South Korea positions it as a key hub for clinical research in APAC.
Opened a new Clinical Trial Support Innovation Center in South Korea to enhance research capabilities.
Zuellig Pharma has unveiled a new state-of-the-art Clinical Trial Support Innovation Center in South Korea. This facility is designed to bolster both domestic and global clinical research efforts by providing advanced infrastructure and services. The center aims to accelerate drug development and enhance the efficiency of clinical trials conducted within and beyond the Korean market.
The establishment of this innovation center in South Korea positions it as a key hub for clinical research in APAC. It will support the development of new medicines by providing cutting-edge infrastructure and services, thereby contributing to the region's growing biopharmaceutical ecosystem and accelerating the availability of novel treatments for patients.
This investment in South Korea enhances the region's capacity for advanced clinical research, supporting global pharmaceutical innovation and potentially leading to faster access to new therapies for APAC populations.
Where this signal fits in the broader landscape.
https://finance.yahoo.com/news/zuellig-pharma-unveils-state-art-023000313.html
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
Sign In